Bod (ASX:BDA) share price soars on United States market entry

The Bod Australia Ltd (ASX: BDA) share price is soaring after the company announced its first purchased order for the United States market.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bod Australia Ltd (ASX: BDA) share price is on the run during early morning trade. This comes after the company announced its first purchased order for the United States market. At the time of writing, the cannabis healthcare company's shares are swapping hands for 50 cents, up 5.26%.

A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares

Image source: Getty Images

What did Bod announce?

Investors are scrambling to buy Bod shares following its latest positive update in a bid to expand its revenue base.

According to this morning's release, Bod advised it has received its initial binding purchase order from Health & Happiness Group. The first of multiple orders for the CBD products are set to be launched into the United States market. This also includes three full-spectrum CBD oil extracts under its premium brand name, CBII.

The products will be available to consumers directly through ecommercial channels sometime in the current first-half of the calendar year. Consequently, Health & Happiness will commence marketing and brand campaigns to create awareness and drive sales in the United States.

The maiden order is valued at $312,000, in which Bod will received a royalty on net product sales. In addition, a cost-plus margin for the supply of the finished goods is also set to create addition revenue streams for Bod.

Delivery of the first lot of CBD products is expected to arrive in the coming months.

The addressable market for CBD consumer products in the United States is estimated to reach around US$6.9 billion by 2025. This represents four times the size that of the United Kingdom's CBD market.

Comments from the CEO

Bod CEO Jo Patterson commented:

The first US purchase order is an exciting step for Bod on two fronts, firstly as it's growing our global footprint, and secondly the US offers a significant opportunity for consumer healthcare CBD products.

Bod will continue to work with H&H to progress additional opportunities in North America. We look forward to updating shareholders on more purchase orders soon.

About the share price

Over the last 12 months, the Bod share price has accelerated to more than 100%, but is relatively flat year-to-date. The company's shares reached a 52-week high of 74 cents last December, before moving in circles.

Based on the current share price, Bod has a market capitalisation of roughly $50.2 million, with 105.8 million shares outstanding.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A boy bounds after a big colourful bouncing ball in a grassy field.
Share Market News

ASX 200 energy shares lead and market finally cracks 8-day losing streak

The ASX 200's painful 8-day slide finally ended on Friday.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Mesoblast, Mineral Resources, and Woolworths shares

Analysts have given their verdict on these shares. Let's see what they are saying.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

These top ASX 200 shares could rise 30% to 40%

Analysts are predicting big things from these shares. Let's find out why.

Read more »

Stacks of coins in a row with each higher than the last, and a person standing on top of each one watching them grow.
Dividend Investing

How I'd invest $2,000 in high-yield ASX 300 shares

I rate these businesses as strong buys for the long-term.

Read more »

A rueful woman tucks into a sweet pie as she contemplates a decision with regret.
Share Fallers

The worst 4 ASX 200 stocks to buy and hold in April unmasked

Investors sent these four ASX 200 stocks tumbling 21% to 44% in April.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Share Fallers

Why these top ASX shares sank 10%+ in April

It was a tough month for these popular shares.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: Netwealth, PLS, and Reliance shares

Morgans has given its verdict on these shares. Let's see what the broker is saying.

Read more »

Two smiling men in high visibility vests and yellow hardhats stand side by side with a large mound of earth and mining equipment behind them smiling as the Carnaby Resources share price rises today
Share Market News

Buy, hold, sell: Capricorn Metals, PLS Group, Fortescue shares

Bell Potter has reviewed its ratings and 12-month price targets on three ASX 200 mining shares.

Read more »